BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 60089)

  • 1. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
    Pircio AW; Gylys JA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of 20681-S and 20682-S, 6-oxo-N-cyclopropylmethylmorphinans, as narcotic antagonist analgesics.
    Hirose K; Matsushita A; Kojima Y; Eigyo M; Jyoyama H; Shiomi T; Tsukinoki Y; Hatakeyama H; Matsubara K; Kawasaki K
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):79-91. PubMed ID: 43119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy reviews: evaluation of butorphanol tartrate.
    Ameer B; Salter FJ
    Am J Hosp Pharm; 1979 Dec; 36(12):1683-91. PubMed ID: 393109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
    Hiyama T; Shintani S; Tsutsui M; Yasuda Y
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitussive properties of butorphanol.
    Cavanagh RL; Gylys JA; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):258-68. PubMed ID: 952583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative gastrointestinal and biliary tract effects of morphine and butorphanol (Stadol).
    Roebel LE; Cavanagh RL; Buyniski JP
    J Med; 1979; 10(4):225-38. PubMed ID: 43349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of nalbuphine hydrochloride.
    Miller RR
    Am J Hosp Pharm; 1980 Jul; 37(7):942-9. PubMed ID: 6994499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies.
    Kalpravidh M; Lumb WV; Wright M; Heath RB
    Am J Vet Res; 1984 Feb; 45(2):217-23. PubMed ID: 6711945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
    O'Callaghan JP; Holtzman SG
    J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assays for narcotic antagonist activity in rodents.
    Pierson AK
    Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal pharmacology of Wy-16,225, a new analgesic agent.
    Malis JL; Rosenthale ME; Gluckman MI
    J Pharmacol Exp Ther; 1975 Sep; 194(3):488-98. PubMed ID: 808600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butorphanol.
    Pachter IJ; Evens RP
    Drug Alcohol Depend; 1985 Feb; 14(3-4):325-38. PubMed ID: 3888579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of butorphanol in horses: dose-response studies.
    Kalpravidh M; Lumb WV; Wright M; Heath RB
    Am J Vet Res; 1984 Feb; 45(2):211-6. PubMed ID: 6711944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcotic-antagonist assay procedures in dogs.
    Dewey WL
    Adv Biochem Psychopharmacol; 1973; 8(0):263-72. PubMed ID: 4794991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.